Acorda Therapeutics, Inc. (ACOR)
Acorda Therapeutics, Inc. is a biopharmaceutical company that focuses on developing therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), and Fampyra (fampridine). The firm also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
Address
TWO BLUE HILL PLAZA
PEARL RIVER, NY 10965
Founded
1995
Number of Employees
102
Website
http://www.acorda.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)